BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 24825907)

  • 1. Transcriptional regulation of oncogenic protein kinase Cϵ (PKCϵ) by STAT1 and Sp1 proteins.
    Wang H; Gutierrez-Uzquiza A; Garg R; Barrio-Real L; Abera MB; Lopez-Haber C; Rosemblit C; Lu H; Abba M; Kazanietz MG
    J Biol Chem; 2014 Jul; 289(28):19823-38. PubMed ID: 24825907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Widespread Exaptation of L1 Transposons for Transcription Factor Binding in Breast Cancer.
    Jiang JC; Rothnagel JA; Upton KR
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer cells forgo translating mRNA transcribed from genes of nonspecialized tasks.
    Ahmed M; Pham TM; Kim HJ; Kim DR
    FEBS Open Bio; 2024 May; 14(5):793-802. PubMed ID: 38467537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PKCε Is an Essential Mediator of Prostate Cancer Bone Metastasis.
    Gutierrez-Uzquiza A; Lopez-Haber C; Jernigan DL; Fatatis A; Kazanietz MG
    Mol Cancer Res; 2015 Sep; 13(9):1336-46. PubMed ID: 26023164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subtype-specific overexpression of the Rac-GEF P-REX1 in breast cancer is associated with promoter hypomethylation.
    Barrio-Real L; Benedetti LG; Engel N; Tu Y; Cho S; Sukumar S; Kazanietz MG
    Breast Cancer Res; 2014 Sep; 16(5):441. PubMed ID: 25248717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling controversy and future therapeutical perspectives of targeting sphingolipid network in cancer immune editing and resistance to tumor necrosis factor-α immunotherapy.
    Sukocheva OA; Neganova ME; Aleksandrova Y; Burcher JT; Chugunova E; Fan R; Tse E; Sethi G; Bishayee A; Liu J
    Cell Commun Signal; 2024 May; 22(1):251. PubMed ID: 38698424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An ErbB Lineage Co-Regulon Harbors Potentially Co-Druggable Targets for Multimodal Precision Therapy in Head and Neck Squamous Cell Carcinoma.
    Bredel M; Kim H; Bonner JA
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein Kinase C Epsilon Overexpression Is Associated With Poor Patient Outcomes in AML and Promotes Daunorubicin Resistance Through p-Glycoprotein-Mediated Drug Efflux.
    Nicholson R; Menezes AC; Azevedo A; Leckenby A; Davies S; Seedhouse C; Gilkes A; Knapper S; Tonks A; Darley RL
    Front Oncol; 2022; 12():840046. PubMed ID: 35707351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Validation of a GPX4-Related Immune Prognostic Signature for Lung Adenocarcinoma.
    Feng Z; Li B; Chen Q; Zhang H; Guo Z; Qin J
    J Oncol; 2022; 2022():9054983. PubMed ID: 35620733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutathione S-Transferases in Cancer.
    Singh RR; Reindl KM
    Antioxidants (Basel); 2021 Apr; 10(5):. PubMed ID: 33946704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of microRNA-205-5p exerts suppressive effects on stem cell drug resistance in gallbladder cancer by down-regulating PRKCE.
    Zhang GF; Wu JC; Wang HY; Jiang WD; Qiu L
    Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32869841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of breast cancer metastasis signaling by miRNAs.
    Petri BJ; Klinge CM
    Cancer Metastasis Rev; 2020 Sep; 39(3):837-886. PubMed ID: 32577859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sp1 is Involved in Vertebrate LC-PUFA Biosynthesis by Upregulating the Expression of Liver Desaturase and Elongase Genes.
    Li Y; Zhao J; Dong Y; Yin Z; Li Y; Liu Y; You C; Monroig Ó; Tocher DR; Wang S
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of MYC-targeting long non-coding RNA MINCR in cell cycle regulation and apoptosis in non-small cell lung Cancer.
    Chen S; Gu T; Lu Z; Qiu L; Xiao G; Zhu X; Li F; Yu H; Li G; Liu H
    Respir Res; 2019 Sep; 20(1):202. PubMed ID: 31481083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of protein kinase C activity inhibits osteosarcoma metastasis.
    Hu HJ; Deng XW; Li RX; Chen DW; Xue C
    Arch Med Sci; 2019 Jul; 15(4):1028-1034. PubMed ID: 31360197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinctive requirement of PKCε in the control of Rho GTPases in epithelial and mesenchymally transformed lung cancer cells.
    Casado-Medrano V; Barrio-Real L; Wang A; Cooke M; Lopez-Haber C; Kazanietz MG
    Oncogene; 2019 Jul; 38(27):5396-5412. PubMed ID: 30923343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COX-2 mediates pro-tumorigenic effects of PKCε in prostate cancer.
    Garg R; Blando JM; Perez CJ; Lal P; Feldman MD; Smyth EM; Ricciotti E; Grosser T; Benavides F; Kazanietz MG
    Oncogene; 2018 Aug; 37(34):4735-4749. PubMed ID: 29765153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical value of miR-182-5p in lung squamous cell carcinoma: a study combining data from TCGA, GEO, and RT-qPCR validation.
    Luo J; Shi K; Yin SY; Tang RX; Chen WJ; Huang LZ; Gan TQ; Cai ZW; Chen G
    World J Surg Oncol; 2018 Apr; 16(1):76. PubMed ID: 29636077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of PKCε downregulation on autophagy in glioblastoma cells.
    Toton E; Romaniuk A; Konieczna N; Hofmann J; Barciszewski J; Rybczynska M
    BMC Cancer; 2018 Feb; 18(1):185. PubMed ID: 29439667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative analysis of mutational and transcriptional profiles reveals driver mutations of metastatic breast cancers.
    Lee JH; Zhao XM; Yoon I; Lee JY; Kwon NH; Wang YY; Lee KM; Lee MJ; Kim J; Moon HG; In Y; Hao JK; Park KM; Noh DY; Han W; Kim S
    Cell Discov; 2016; 2():16025. PubMed ID: 27625789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.